Organisation
Neglected Tropical Diseases
Research Unit
Projects
1 - 10 of 51
- An economic evaluation of strategies for sleeping sickness eliminationFrom3 Jul 2019 → Today
- Community Participation in Neglected Tropical Diseases Elimination: A case study of Human African Trypanosomiasis elimination in Democratic Republic of CongoFrom3 Jul 2019 → Today
- The role of innovative tools for sand fly control in the visceral leishmaniasis (VL) elimination initiative in the South-East-Asian regionFrom11 Apr 2019 → Today
- Cryptic human and animal reservoirs compromise the sustainedelimination of gambiense-human African trypanosomiasis in the Democratic Republic of the CongoFrom1 Dec 2018 → 30 Nov 2023
- Azithromycin and opportunities for integrated control of Neglected Tropical DiseasesFrom1 Nov 2018 → 31 Jan 2020
- A systemic insecticide to control zoonotic cutaneous leishmaniasis in Errachidia province - Southeastern Morocco: an intervention trial for an innovative vector control toolFrom1 Nov 2018 → 31 Dec 2023
- Post exposure prophylaxis for leprosy in the Comoros and MadagascarFrom1 Sep 2018 → 28 Feb 2023
- Innovative strategies to ascertain the Elimination of Visceral Leishmaniasis in NepalFrom11 Jul 2018 → Today
- Non-commercial clinical research in neglected tropical diseasesFrom11 Jul 2018 → 31 Dec 2020
- To strengthen Institute of Tropical Medicine Pedro Kouri (IPK, Cuba) and National Institute of Hygiene, Epidemiology and Microbiology (INHEM, Cuba) towards accomplishment of their academic mission through capacity building and scientific co-operation.From1 Jan 2018 → 31 Dec 2018
Publications
111 - 120 of 445
- Chemoprophylaxis for Pneumocystis carinii pneumonia [letter](1999)
Authors: R Colebunders, DANNY DENOLF, K Verdonck
Pages: 662 - Iodine deficiency mitigates growth retardation and osteopenia in selenium-deficient rats(2006)
Authors: R. Moreno-Reyes, D Egrise, M Boelaert, S Goldman, S Meuris
Pages: 595-600 - A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis(2006)
Authors: F. Chappuis, Suman Rijal, A Soto, J Menten, M Boelaert
Pages: 723-726 - Lest we forget: neuropsychiatry and the new generation anti-HIV drugs [letter](1999)
Authors: R Colebunders, K Verdonck
Pages: 869 - Who pays and who benefits from health care? An assessment of equity in health care financing and benefit distribution in Tanzania(2012)
Authors: G. Mtei, S. Makawia, M Ally, A Kuwawenaruwa, F Meheus, J. Borghi
Pages: i23-i24 - Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda(2002)
Authors: PJ Guerin, P Oliaro, Shyam Sundar, M Boelaert, SL Croft, P Desjeux, MK Wasunna, ADM Bryceson
Pages: 494-501 - Sodium stibogluconate cardiotoxicity and safety of generics(2003)
Authors: Suman Rijal, F. Chappuis, R. Singh, M Boelaert, L Loutan, S Koirala
Pages: 597-598 - Residual activity and integrity of PermaNet((R)) 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral leishmaniasis in India and Nepal(2012)
Authors: A. Picado, SP Singh, V Vanlerberghe, Surendra Uranw, B Ostyn, H. Kaur, ML Das, Shyam Sundar, Suman Rijal, P Tungu, et al.
Pages: 150-159 - NTD control and health system strengthening [letter](2012)
Authors: F. Meheus, Suman Rijal, Pascal Lutumba, D Hendrickx, M Boelaert
Pages: 2149-2150 - Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency? [viewpoint](2012)
Authors: E Hasker, Pascal Lutumba, F. Chappuis, V Kande, J. Potet, Anja De Weggheleire, C. Kambo, Evelyn Depoortere, B. Pécoul, M Boelaert
Pages: e1950